Home » Topics » Regulatory » Patents

Patents
RSS

Synthelabo describes new series of serotonergic antagonists

Nov. 24, 1998

Antiinflammatory tetrazoles in development at Ono

Nov. 23, 1998

Merck & Co. presents potent and selective sst2 receptor agonists

Nov. 23, 1998

Bayer claims broad-spectrum oxazolidinones

Nov. 23, 1998

New MRI contrast agents with favorable neurotoxicity profile developed at Bracco

Nov. 23, 1998

Osteoclast differentiation inhibitors for arthritis under study at Sumitomo

Nov. 23, 1998

Dual NK1 and NK2 receptor antagonists under study at Sankyo for respiratory disorders, incontinence

Nov. 20, 1998

Antitumor tetramic acid compound produced by Streptomyces

Nov. 20, 1998

Erythromycin derivatives with high activity against sensitive and resistant microorganisms

Nov. 20, 1998

Picornavirus protease inhibitors from Agouron especially useful for rhinovirus infections

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.